The alpha(v)beta(3) integrin is abundantly expressed in osteoclasts and has been implicated in the regulation of osteoclast function, especially in cell attachment. However, in vivo studies have shown that echistatin, an RGD-containing disintegrin which binds to alpha(v)beta(3), inhibits bone resorption without changing the number of osteoclasts on the bone surface, suggesting inhibition of osteoclast activity. The objective of this study was to examine how occupancy of alpha(v)beta(3) integrins inhibits osteoclast function, using primary rat osteoclasts and murine pre-fusion osteoclast-like cells formed in a co-culture system. We show that: (1) echistatin inhibits bone resorption in vitro at lower concentrations (IC(50)= 0.1 nM) than those required to detach osteoclasts from bone (IC(50) approximately 1 microM); (2) echistatin (IC(50)= 0.1 nM) inhibits M-CSF-induced migration and cell spreading of osteoclasts; (3) alpha(v)beta(3) integrins are localized in podosomes at the leading edge of migrating osteoclasts, whereas, with echistatin treatment (0.1 nM), alpha(v)beta(3) disperses randomly throughout the adhesion surface; and (4) when bone resorption is fully inhibited with echistatin, there is visible disruption of the sealing zone (IC(50)= 13 nM), and alpha(v)beta(3) visualized with confocal microscopy re-distributes from the basolateral membranes to intracellular vesicular structures. Taken together, these findings suggest that alpha(v)beta(3) integrin plays a role in the regulation of two processes required for effective osteoclastic bone resorption: cell migration (IC(50)= 0.1 nM) and maintenance of the sealing zone (IC(50) approximately 10 nM).
REFERENCES
REFERENCES
Chambers
T. J.
, Fuller
K.
, Darby
J. A.
, Pringle
J. A. S.
, Horton
M. A.
(1986
). Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro.
Bone Miner
1
, 127
–135
Chenu
C.
, Colucci
S.
, Grano
M.
, Zigrino
P.
, Barattolo
R.
, Zambonin
G.
, Baldini
N.
, Delmas
P. D.
, Zambonin-Zallone
A.
(1994
). Osteocalcin induces chemotaxis, secretion of matrix proteins and calcium-mediated intracellular signaling in human osteoclast-like cells.
J. Cell Biol
127
, 1149
–1158
Clark
E. A.
, Brugge
J. S.
(1995
). Integrins and signal transduction pathways: The road taken.
Science
268
, 233
–239
Clyman
R. I.
, Mauray
F.
, Kramer
R. H.
(1992
). Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix.
Exp. Cell Res
200
, 272
–284
Colucci
S.
, Giannelli
G.
, Grano
M.
, Faccio
R.
, Quaranta
V.
, Zambonin-Zallone
A.
(1996
). Human osteoclast-like cells selectively recognize laminin isoform, an event that induces migration and activates Ca2+mediated signals.
J. Cell Sci
109
, 1527
–1535
Crippes
B. A.
, Engleman
V. W.
, Settle
S. L.
, Delarco
J.
, Ornberg
R. L.
, Helfrich
M. H.
, Horton
M. A.
, Nickols
G. A.
(1996
). Antibody to3integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidecto-mized rat.
Endocrinology
137
, 918
–924
Davies
J.
, Warwick
J.
, Totty
N.
, Philp
R.
, Horton
M.
(1989
). The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor.
J. Cell Biol
109
, 1817
–1826
Engleman
V. W.
, Nickols
G. A.
, Ross
F. P.
, Horton
M. A.
, Griggs
D. W.
, Settle
S. L.
, Ruminski
P. G.
, Teitelbaum
S. L.
(1997
). A peptidomimetic antagonist of thev 3integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
J. Clin. Invest
99
, 2284
–2292
Fisher
J. E.
, Caulfield
M. P.
, Sato
M.
, Quartuccio
H. A.
, Gould
R. J.
, Garsky
V. M.
, Rodan
G. A.
, Rosenblatt
M.
(1993
). Inhibition of osteoclastic bone resorption in vivo by echistatin, an ‘arginyl-glycyl-aspartyl’(RGD)-containing protein.
Endocrinology
132
, 1411
–1413
Fuller
K.
, Owens
J. M.
, Jagger
C. J.
, Wilson
A.
, Moss
R.
, Chambers
T. J.
(1993
). Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts.
J. Exp. Med
178
, 1733
–1744
Helfrich
M. H.
, Nesbitt
S. A.
, Horton
M. A.
(1992
). Integrins on rat osteoclasts: characterization of two monoclonal antibodies (F4 and F11) to rat3.
J. Bone Miner. Res
7
, 345
–351
Horton
M. A.
, Taylor
M. L.
, Arnett
T. R.
, Helfrich
M. H.
(1991
). Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
Exp. Cell Res
195
, 368
–375
Hynes
R. O.
(1992
). Integrins: versatility, modulation, and signaling in cell adhesion.
Cell
69
, 11
–25
Jaconi
M. E.
, Theler
J. M.
, Schlegel
W.
, Appel
R. D.
, Wright
S. D.
, Lew
P. D.
(1991
). Multiple elevations of cytosolic-free Ca2+in human neutrophils: initiation by adherence receptors of the integrin family.
J. Cell Biol
112
, 1249
–1257
King
K. L.
, D'Anza
J. J.
, Bodary
S.
, Pitti
R.
, Siegel
M.
, Lazarus
R. A.
, Dennis
M. S.
, Hammonds
R. G.
Jr., Kukreja
S. C.
(1994
). Effects of kistrin on bone resorption in vitro and serum calcium in vivo.
J. Bone Miner. Res
9
, 381
–387
Lakkakorpi
P. T.
, Horton
M. A.
, Helfrich
M. H.
, Karhukorpi
E.-K.
, Väänänen
H. K.
(1991
). Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface.
J. Cell Biol
115
, 1179
–1186
Lawson
M. A.
, Maxfield
F. R.
(1995
). Ca++-and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils.
Nature
377
, 75
–79
Leavesley
D. I.
, Schwartz
M. A.
, Rosenfeld
M.
, Cheresh
D. A.
(1993
). Integrin1-and 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms.
J. Cell Biol
121
, 163
–170
Liaw
L.
, Skinner
M. P.
, Raines
E. W.
, Ross
R.
, Cheresh
D.
, Schwartz
S. M.
, Giachelli
C. M.
(1995
). The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins.
J. Clin. Invest
95
, 713
–724
Masarachia
P.
, Yamamoto
M.
, Leu
C.-T.
, Rodan
G.
, Duong
L. T.
(1998
). Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism.
Endocrinology
139
, 1401
–1410
McHugh
K. P.
, Hodivala-Dilke
K.
, Cheng
S.-L.
, Zheng
M. H.
, Avioli
L. V.
, Hynes
R. O.
, Ross
F. P.
, Teitelbaum
S. L.
(1998
). The3integrin knockout mouse is osteosclerotic and has dysfunctional osteoblasts.
Bone
23
, 191
–.Nakamura
I.
, Gailit
J.
, Sasaki
T.
(1996
). Osteoclast integrinv 3is present in the clear zone and contributes to cellular polarization.
Cell Tissue Res
286
, 507
–515
Nakamura
I.
, Tanaka
H.
, Rodan
G. A.
, Duong
L. T.
(1998
). Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells.
Endocrinology
139
, 5182
–5193
Nesbitt
S.
, Nesbit
A.
, Helfrich
M.
, Horton
M.
(1993
). Biochemical characterization of human osteoclast integrins: osteoclasts expressv 3,2 1, andv 1integrins.
J. Biol. Chem
268
, 16737
–16745
Pilkington
M. F.
, Sims
S. M.
, Dixon
S. J.
(1998
). Wortmannin inhibits spreading and chemotaxis of rat osteoclasts in vitro.
J. Bone Miner. Res
13
, 688
–694
Roodman
G. D.
(1996
). Advances in bone biology: The osteoclast.
Endocr. Rev.
17
, 308
–332
Sato
M.
, Sardana
M. K.
, Grasser
W. A.
, Garsky
V. M.
, Murray
J. M.
, Gould
R. J.
(1990
). Echistatin is a potent inhibitor of bone resorption in culture.
J. Cell Biol
111
, 1713
–1723
Sato
M.
, Garsky
V. M.
, Majeska
R. J.
, Einhorn
T. A.
, Murray
J.
, Tashjian
A. H.
Jr., Gould
R. J.
(1994
). Structure-activity studies of the s-echistatin inhibition of bone resorption.
J. Bone Miner. Res
9
, 1441
–1449
Schwartz
M. A.
(1993
). Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium.
J. Cell Biol
120
, 1003
–1010
Shankar
G.
, Davison
I.
, Helfrich
M. H.
, Mason
W. T.
, Horton
M. A.
(1993
). Integrin receptor-mediated mobilization of intracellular calcium in rat osteoclasts.
J. Cell Sci
105
, 61
–68
Simon
K. O.
, Nutt
E. M.
, Abraham
D. G.
, Rodan
G. A.
, Duong
L. T.
(1997
). Thev 3integrin regulates-mediated cell migration toward fibronectin.
J. Biol. Chem
272
, 29380
–29389
Wesolowski
G.
, Duong
L. T.
, Lakkakorpi
P. T.
, Nagy
R. M.
, Tezuka
K.
, Tanaka
H.
, Rodan
G. A.
, Rodan
S. B.
(1995
). Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells.
Exp. Cell Res
219
, 679
–686
Yamamoto
M.
, Fisher
J. E.
, Gentile
M.
, Seedor
J. G.
, Leu
C.-T.
, Rodan
S. B.
, Rodan
G. A.
(1998
). The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats.
Endocrinology
139
, 1411
–1419
Zimolo
Z.
, Wesolowski
G.
, Tanaka
H.
, Hyman
J. L.
, Hoyer
J. R.
, Rodan
G. A.
(1994
). Solublev 3integrin ligands raise [Ca2+]iin rat osteoclasts and mouse-derived osteoclast-like cells.
Am. J. Physiol
266
, 376
–.
This content is only available via PDF.
© 1999 by Company of Biologists
1999
